Hyaluronic Viscosupplementation Market

Future Market Insights

Key Insight

The hyaluronic viscosupplementation market is projected to grow from USD 2.7 billion in 2025 to USD 4.3 billion by 2035, at a CAGR of 4.9%. Single Injection Knee Hyaluronic Acid Injections will dominate with a 32.2% market share, while knee will lead the body parts segment with a 35.6% share.

September 26, 2025

Anurag Sharma

264 Pages

Cite this Report

Hyaluronic Viscosupplementation Market

https://www.futuremarketinsights.com/reports/hyaluronic-viscosupplementation-market

License

Buy Now

Summary ToC Companies

Key Players

Bioiberica S.A.U
Bioventus LLC
Chugai Pharmaceutical Co. Ltd
Hangzhou Singclean Medical Products Co. Ltd
Hanmi Pharm. Co. Ltd
Maxigen Biotech Inc
Meiji Seika Pharma
L'Oréal
Seikagaku Corporation
Yuria-Pharm LLC

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hyaluronic Viscosupplementation Market

Key Players

Similar Industry Reports